Posts Tagged ‘ACC.13’

March 21st, 2013

DIGging In: Three Reasons Why the Recent Digoxin Study Is Not Relevant to Readmission

The evidence is just not compelling that this this drug would reduce hospital readmissions

March 14th, 2013

Fibrinolysis Now or Primary PCI Later?

, and

CardioExchange’s Rick Lange and David Hillis ask Frans Van de Werf, principal investigator for the STREAM study, about his study group’s findings and their implications for clinical practice. THE STUDY In the STREAM trial, investigators compared two treatment strategies in STEMI patients presenting early after symptom onset who were unable to undergo primary PCI within 1 hour: […]

March 12th, 2013

Too Long, Too Short, or Just Right?

What would be a better format for ACC?

March 11th, 2013

The Affordable Care Act: The Carrots Are Becoming Sticks

Before our eyes, the Affordable Care Act is attempting to change the traditional incentive structure of the American health care system.

March 11th, 2013

Diversity in Cardiology: Blogging from ACC.13

What can be done to increase the numbers of women and minorities at ACC.13 and in cardiology in general?

March 11th, 2013

The Human Touch After Hours and Between Sessions: Blogging from ACC.13

Much of medical training in spent paying respect to a strict hierarchy, and these meetings allow for mentors and mentees to interact as peers.

March 11th, 2013

Devices vs. Drugs: A Distinction Without a Difference? Blogging from ACC.13

How are devices regulated? Due to some quirks, the tail now wags the dog.

March 11th, 2013

Hoping for Good Data from Partner II B: Blogging from ACC.13

Walking the walk on TAVR

March 10th, 2013

A Renaissance for the Poster: Blogging from ACC.13

Putting the posters in the Expo Hall pays off

March 10th, 2013

Learning to Network: Blogging from ACC.13

At prior ACC meetings, I had not made such a concerted effort to speak with the luminaries in our field and, unfortunately, this was a monumental mistake.